Inscription Capital’s Counterpoint Quantitative Equity ETF CPAI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.16M Buy
99,642
+62,100
+165% +$2.68M 0.44% 37
2025
Q4
$1.51M Buy
37,542
+5,892
+19% +$233K 0.15% 104
2025
Q3
$1.25M Buy
31,650
+1,550
+5% +$57.2K 0.13% 137
2025
Q2
$1.12M Buy
+30,100
New +$1.02M 0.16% 99

Other funds holding CPAI

Inscription Capital's CPAI Position: Q1 2026 in Review

Inscription Capital increased its Counterpoint Quantitative Equity ETF (CPAI) stake by 165% in Q1 2026, buying an estimated $2.68M and bringing the position to 99,642 shares worth $4.16M. The position accounts for 0.44% of the portfolio, ranked #37.

Inscription Capital first reported a position in CPAI in Q2 2025 and has held it in 4 quarters since. 33 funds tracked by Wall St. Rank hold CPAI as of Q1 2026.

  • Inscription Capital held 99,642 shares of Counterpoint Quantitative Equity ETF worth $4.16M as of Q1 2026.
  • Inscription Capital bought 62,100 Counterpoint Quantitative Equity ETF shares in Q1 2026, an estimated $2.68M.
  • Counterpoint Quantitative Equity ETF made up 0.44% of Inscription Capital's portfolio in Q1 2026, its #37 holding.
  • Inscription Capital first reported a position in Counterpoint Quantitative Equity ETF in Q2 2025 and has held it in 4 quarters since.
  • 33 funds tracked by Wall St. Rank held Counterpoint Quantitative Equity ETF as of Q1 2026.

Based on Inscription Capital's 13F filing for Q1 2026, filed 20 Apr 2026.